Cardiovascular Morbidity in Diabetic Non-Alcoholic Fatty Liver Disease (NAFLD) Using NAFLD Fibrosis Score as an Early Indicator
Priti SHAHAPURE, Shimpa SHARMA
(Endocrinol Res Pract 2020; 24: 314-320) DOI: 10.25179/tjem.2020-77679
Priti SHAHAPURE, Shimpa SHARMA
(Endocrinol Res Pract 2020; 24: 314-320) DOI: 10.25179/tjem.2020-77679
Murat ŞAHİN, Ayten OĞUZ, Dilek TÜZÜN, Semiha ÇALKAYA, Kamile GÜL
(Endocrinol Res Pract 2019; 23: 197-205) DOI: 10.25179/tjem.2019-70493
Mehtap EVRAN OLGUN, Gamze AKKUŞ, Mustafa GÖK, Çağlar Emre ÇAĞLIYAN, İlker ÜNAL, Murat SERT, Tamer TETİKER
(Endocrinol Res Pract 2019; 23: 97-104) DOI: 10.25179/tjem.2018-63768